FSN E-Commerce (NYKAA)
Fast GrowerFairStock Score: 53/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹331 |
| Market Cap | ₹94,834.47 Cr |
| P/E Ratio | 371.91 |
| ROCE | 9.59% |
| ROE | 10.86% |
| Dividend Yield | 0% |
| Profit Growth | 517.34% |
| Debt/Equity | 0.83 |
| Sales Growth | 999% |
| Free Cash Flow | ₹262 Cr |
| Promoter Holding | 52.1% |
| 52-Week Range | ₹227.9 — ₹351 |
| Sector | Retailing |
| Book Value | ₹5.02 |
Strengths
- Strong growth track record: 5-year revenue CAGR of 26.64% and latest sales growth of 19.87%.
- Profit growth of 118.49% shows improving earnings momentum.
- Healthy financial solvency indicators: Piotroski F-Score of 8/9 and Altman Z-Score of 14.70.
- Positive free cash flow of ₹262 Cr and promoter holding of 52.10% support long-term alignment.
- Debt/Equity of 1.01 appears manageable for a capital-light e-commerce/omni-channel retail model.
Concerns
- Extreme valuation: P/E of 502.01, P/B of 57.48, and EV/EBITDA of 191.77 leave no margin of safety.
- Thin profitability: latest quarter net profit is only ₹68 Cr on ₹2,873 Cr sales, roughly 2.4% PAT margin.
- ROE of 10.86% and ROCE of 9.59% are modest relative to the premium multiple paid.
- Growth is decelerating from 5-year CAGR of 26.64% to 19.87%; any slowdown could compress the high multiple sharply.
AI Analysis
Let me first acknowledge what FSN E-Commerce has done well. It has built a beauty-retail business in India with a 5-year revenue CAGR of 26.64%, latest sales growth of 19.87%, and profit growth of 118.49%. The balance sheet is not in immediate danger: the Piotroski F-Score of 8/9, Altman Z-Score of 14.70, and positive free cash flow of ₹262 Cr indicate a solvent business with reasonable operating health. Promoters still own 52.10%, so interest alignment is there. But my job is to buy value, not narratives. At ₹261.55, the market is asking me to pay ₹76,008 Cr for a company whose trailing earnings are roughly ₹151 Cr. That is a P/E of 502. EV/EBITDA stands at 191.77, and P/B is 57.48 for a business earning only 10.86% ROE and 9.59% ROCE. The latest quarter's net profit of ₹68 Cr on revenue of ₹2,873 Cr translates to a thin margin of about 2.4%. This is not the kind of earnings power that justifies a three-figure multiple. Graham's discipline says price and value must eventually meet; at these levels, safety is absent. The Graham Number works out to ₹7.08, DCF value to ₹48.84, and margin of safety is deeply negative at -3,650%. Even allowing for high-quality growth, I cannot find compensation for that risk. This may be a fine company, but it is not a fine investment at this price. I admire growth; I refuse to pay for it decades in advance. I would keep it on my watchlist, not in my portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer